Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  370 results for ""Antibodies, Viral""

Your Filters

Publisher : wiley-liss Subject : antibody formation Subject : covid-19 Subject : emotional engagement Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody.

  • Authors : Pan Y; Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei, China.; Hubei Engineering Center for Infectious Disease Prevention, Control and Treatment, Wuhan, Hubei, China.

Subjects: Antibodies, Viral* ; Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28356.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody response to the third dose of inactivated COVID-19 vaccine in people living with HIV (PLWH): A longitudinal cohort.

  • Authors : Zeng G; Department of HIV/AIDS Prevention and Control, Shenzhen Center for Disease Control and Prevention, Shenzhen, China.; School of Public Health, Hengyang Medical School, University of South China, Hengyang, China.

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Journal of medical virology [J Med Virol] 2023 May; Vol. 95 (5), pp. e28797.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Antibody response 6 months after the booster dose of Pfizer in previous recipients of CoronaVac.

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Humans

  • Source: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28169. Date of Electronic Publication: 2022 Oct 01.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Unremarkable antibody responses against various infectious agents after inoculation with the BNT162b2 COVID-19 vaccine.

  • Authors : Kozawa K; Department of Pediatrics, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Miura H

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Antibodies, Viral

  • Source: Journal of medical virology [J Med Virol] 2022 Oct; Vol. 94 (10), pp. 4583-4585. Date of Electronic Publication: 2022 Jun 09.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Antibody responses of the first wave of survivors infected with SARS-CoV-2 1 year ago.

  • Authors : He L; Physical Examination Center, Renmin Hospital of Wuhan University, Wuhan, China.; Zeng C

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/immunology; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood

  • Source: Journal of medical virology [J Med Virol] 2022 May; Vol. 94 (5), pp. 1770-1772. Date of Electronic Publication: 2022 Jan 05.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Dynamics of antibody response to CoronaVac vaccine.

Subjects: Antibody Formation* ; COVID-19*/COVID-19*/COVID-19*/prevention & control; Antibodies, Viral

  • Source: Journal of medical virology [J Med Virol] 2022 May; Vol. 94 (5), pp. 2139-2148. Date of Electronic Publication: 2022 Jan 28.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.

  • Authors : Chen Y; Wuhan Huoshenshan Hospital, Wuhan, China.; Chinese PLA Center for Disease Control and Prevention, Beijing, China.

Subjects: Antibody Formation* ; COVID-19 Drug Treatment*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

  • Source: Journal of medical virology [J Med Virol] 2021 May; Vol. 93 (5), pp. 2782-2789. Date of Electronic Publication: 2021 Mar 01.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Report

Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.

  • Authors : Shang Y; Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, China.; Liu T

Subjects: Antibody Formation*; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*blood ; COVID-19/COVID-19/COVID-19/*immunology

  • Source: Journal of medical virology [J Med Virol] 2021 Feb; Vol. 93 (2), pp. 612-614. Date of Electronic Publication: 2020 Aug 21.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

Hybrid immunity by two COVID-19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2.

  • Authors : Almanzar G; Department of Pediatrics, Pediatric Rheumatology/Special Immunology, University Hospital Würzburg, Würzburg, Germany.; Koosha K

Subjects: COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood COVID-19 breakthrough infections

  • Source: Journal of medical virology [J Med Virol] 2024 Jun; Vol. 96 (6), pp. e29739.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

A flow cytometry-based assay to measure neutralizing antibodies against SARS-CoV-2 virus.

  • Authors : Pscheidt VM; Immunotherapy Laboratory - (LAIT) - Department of Basic Health Sciences of Federal University of Health Sciences of Porto Alegre, UFCSPA, Porto Alegre, Brazil.; de Souza PO

Subjects: Flow Cytometry*/Flow Cytometry*/Flow Cytometry*/methods ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology

  • Source: Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2024 Jun; Vol. 105 (6), pp. 446-457. Date of Electronic Publication: 2024 Apr 16.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235694 Publication Model: Print-Electronic Cited

Record details

Read More Add to Saved list
×
  • 1-10 of  370 results for ""Antibodies, Viral""